Wondering about the most recent progress in Myasthenia Gravis treatments research and clinical trials?
Wondering about the most recent progress in myasthenia gravis treatments research and clinical trials?
Join a “What’s New in MG Research” webinar to learn about the latest research results, key clinical trial phases, and current outcomes from top research trials taking place right now.
Webinar: Add-On Muscle-Targeted Therapy for Generalized Myasthenia Gravis: Introduction to NMD670
Tuesday, September 9 @ 2:00 PM Eastern Time (US and Canada)
Join us to learn about new add-on muscle targeted therapy, a novel oral medication that is being developed by NMD Pharma for generalized myasthenia gravis (gMG). NMD Pharma clinical team, together with Professor James Howard, MD, FAAN, will explain how this molecule works and the science behind it. They’ll also introduce NMD Pharma’s ongoing clinical trial and how you can join it, if interested.
This webinar is sponsored by NMD Pharma.
Register Now
Presenting Partners
Recent Webinars
